JP Morgan Chase
NVAX icon

JP Morgan Chase’s Novavax NVAX Stock Holding History

JP Morgan Chase’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$608K Buy
75,200
+2,995
+4% +$27.1K ﹤0.01% 4881
2025
Q4 		$485K Sell
72,205
-813
-1% -$6.13K ﹤0.01% 5074
2025
Q3 		$633K Sell
73,018
-11,253
-13% -$87.6K ﹤0.01% 4889
2025
Q2 		$531K Buy
84,271
+2,282
+3% +$15.1K ﹤0.01% 4747
2025
Q1 		$526K Buy
81,989
+5,413
+7% +$44.7K ﹤0.01% 4740
2024
Q4 		$616K Sell
76,576
-3,299
-4% -$31.8K ﹤0.01% 4924
2024
Q3 		$1.01M Sell
79,875
-4,040
-5% -$52.2K ﹤0.01% 4465
2024
Q2 		$1.06M Sell
83,915
-34,376
-29% -$346K ﹤0.01% 4231
2024
Q1 		$565K Sell
118,291
-41,923
-26% -$194K ﹤0.01% 4725
2023
Q4 		$769K Buy
160,214
+25,687
+19% +$157K ﹤0.01% 4513
2023
Q3 		$974K Sell
134,527
-3,132
-2% -$25K ﹤0.01% 4089
2023
Q2 		$1.02M Buy
137,659
+46,386
+51% +$365K ﹤0.01% 4055
2023
Q1 		$632K Buy
91,273
+46,001
+102% +$423K ﹤0.01% 4340
2022
Q4 		$465K Sell
45,272
-6,718
-13% -$119K ﹤0.01% 4571
2022
Q3 		$946K Sell
51,990
-5,001
-9% -$217K ﹤0.01% 4045
2022
Q2 		$2.93M Sell
56,991
-13,345
-19% -$691K ﹤0.01% 3242
2022
Q1 		$5.18M Buy
70,336
+10,277
+17% +$916K ﹤0.01% 2971
2021
Q4 		$8.59M Sell
60,059
-199,329
-77% -$34.2M ﹤0.01% 2585
2021
Q3 		$53.8M Buy
259,388
+179,161
+223% +$39.5M 0.01% 1144
2021
Q2 		$17M Sell
80,227
-382,062
-83% -$70M ﹤0.01% 1985
2021
Q1 		$83.8M Buy
462,289
+232,064
+101% +$46.2M 0.01% 928
2020
Q4 		$25.7M Buy
230,225
+87,198
+61% +$9.27M ﹤0.01% 1438
2020
Q3 		$15.4M Buy
143,027
+123,377
+628% +$15M ﹤0.01% 1684
2020
Q2 		$1.64M Sell
19,650
-414,876
-95% -$15.9M ﹤0.01% 3232
2020
Q1 		$5.9M Buy
434,526
+160,205
+58% +$1.36M ﹤0.01% 2127
2019
Q4 		$1.09M Sell
274,321
-7,727
-3% -$33.5K ﹤0.01% 3788
2019
Q3 		$1.42M Buy
282,048
+275,215
+4,028% +$1.51M ﹤0.01% 3633
2019
Q2 		$42K Sell
6,833
-62,195
-90% -$489K ﹤0.01% 5244
2019
Q1 		$760K Sell
69,028
-262,538
-79% -$8.29M ﹤0.01% 3963
2018
Q4 		$12.2M Buy
331,566
+19,743
+6% +$765K ﹤0.01% 1845
2018
Q3 		$11.7M Buy
311,823
+83,748
+37% +$2.36M ﹤0.01% 2065
2018
Q2 		$6.11M Sell
228,075
-125,976
-36% -$4.26M ﹤0.01% 2524
2018
Q1 		$14.9M Buy
354,051
+12,768
+4% +$513K ﹤0.01% 1739
2017
Q4 		$8.46M Buy
341,283
+31,366
+10% +$765K ﹤0.01% 2259
2017
Q3 		$7.13M Buy
309,917
+50,092
+19% +$1.12M ﹤0.01% 2274
2017
Q2 		$5.98M Buy
259,825
+74,420
+40% +$1.46M ﹤0.01% 2361
2017
Q1 		$4.75M Buy
185,405
+54,769
+42% +$1.51M ﹤0.01% 2467
2016
Q4 		$3.29M Sell
130,636
-47,876
-27% -$1.4M ﹤0.01% 2753
2016
Q3 		$7.43M Buy
178,512
+93,688
+110% +$12.1M ﹤0.01% 1974
2016
Q2 		$12.3M Buy
84,824
+19,012
+29% +$2.18M ﹤0.01% 1716
2016
Q1 		$6.79M Buy
65,812
+65,101
+9,156% +$6.98M ﹤0.01% 2020
2015
Q4 		$119K Buy
711
+28
+4% +$4.31K ﹤0.01% 3755
2015
Q3 		$96K Buy
683
+10
+1% +$2.24K ﹤0.01% 3758
2015
Q2 		$150K Sell
673
-629
-48% -$111K ﹤0.01% 3845
2015
Q1 		$216K Buy
1,302
+633
+95% +$103K ﹤0.01% 3803
2014
Q4 		$79K Sell
669
-874
-57% -$91.3K ﹤0.01% 4117
2014
Q3 		$129K Buy
+1,543
New +$139K ﹤0.01% 4065
2014
Q1 		– Sell
-2,097
Closed -$215K – 3828
2013
Q4 		$215K Buy
2,097
+614
+41% +$43.4K ﹤0.01% 3800
2013
Q3 		$94K Sell
1,483
-238
-14% -$13.4K ﹤0.01% 4188
2013
Q2 		$71K Buy
+1,721
New +$74.6K ﹤0.01% 4223

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's NVAX Position: Q1 2026 in Review

JP Morgan Chase increased its Novavax (NVAX) stake by 4.1% in Q1 2026, buying an estimated $27.1K and bringing the position to 75,200 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #4881.

JP Morgan Chase first reported a position in NVAX in Q2 2013 and has held it in 50 quarters since. The position peaked at $83.8M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • JP Morgan Chase held 75,200 shares of Novavax worth $608K as of Q1 2026.
  • JP Morgan Chase bought 2,995 Novavax shares in Q1 2026, an estimated $27.1K.
  • Novavax made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4881 holding.
  • JP Morgan Chase first reported a position in Novavax in Q2 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's Novavax position peaked at $83.8M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.